Abstract:Objective To investigate the effects and the mechanism of Xuezhikang on fatty liver disease.Methods Sixteen male Wistar rats were fed with hypercholesterol diet for 6 weeks,and then were randomly divided into two groups:model group:fed with cholesterol diet for 6 weeks; Xuezhikang group:fed with the same cholesterol diet and 300 mg/(kg·d) Xuezhikang for 6 weeks.Control group was fed with normal diet for 12 weeks.The change of serum lipid profile, pathomorphism of hepatic tissue as well as PPARy protein,caveolin-1 protein expression and level of malondialdehyde(MDA),activity of superoxide dismutase(SOD) in the livers were detected at the end of the study.Results Rats of fatty liver group showed higher serum levels of total cholesterol, low density lipoprotein cholesterol(P<C0.01 ),and significantly more significant liver steatosis than those of control group.Treatment with Xuezhikang could significantly reduce the levels of triglyceride,total cholesterol and low density lipoprotein cholesteroK P<0.05') in serum,decrease MDA(P<0.05) and increase activity of SOD in the liver.Xuezhikang also could significantly improve liver steatosis,increase PPARy protein and decrease caveolin-1 protein in the fatty livers. Conclusion Xuezhikang decreased the serum cholesterol,upregulated PPARy protein expression and decresed caveolin-1 protein expression in the hepatic tissue,which may inhibit the formation of fatty liver.

Effects of Xuezhikang on PPAR-Y and caveolin-1 in liver of rats with fatty liver disease